Johimbin (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Johimbin" in Serbian language version.

refsWebsite

Global rank Serbian rank

5nih.gov

4^th place

8^th place

4doi.org

2^nd place

4^th place

2archive.org

6^th place

5^th place

1web.archive.org

1^st place

1unc.edu

1,538^th place

3,389^th place

archive.org

Kaumann AJ (1983). „Yohimbine and rauwolscine inhibit 5-hydroxytryptamine-induced contraction of large coronary arteries of calf through blockade of 5 HT2 receptors”. Naunyn-Schmiedeberg's Archives of Pharmacology. 323 (2): 149—54. PMID 6136920. doi:10.1007/BF00634263.
Baxter GS, Murphy OE, Blackburn TP (1994). „Further characterization of 5-hydroxytryptamine receptors (putative 5-HT2B) in rat stomach fundus longitudinal muscle”. British Journal of Pharmacology. 112 (1): 323—31. PMC 1910288 . PMID 8032658.

doi.org

Rosengren, A. H.; Jokubka, R.; Tojjar, D.; Granhall, C.; Hansson, O.; Li, D.-Q.; Nagaraj, V.; Reinbothe, T. M.; Tuncel, J. (2009). „Overexpression of Alpha2A-Adrenergic Receptors Contributes to Type 2 Diabetes”. Science. 327 (5962): 217—20. PMID 19965390. doi:10.1126/science.1176827.
Millan MJ; Newman-Tancredi A; Audinot V; et al. (2000). „Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states”. Synapse. 35 (2): 79—95. PMID 10611634. doi:10.1002/(SICI)1098-2396(200002)35:2<79::AID-SYN1>3.0.CO;2-X.
Arthur JM, Casañas SJ, Raymond JR (1993). „Partial agonist properties of rauwolscine and yohimbine for the inhibition of adenylyl cyclase by recombinant human 5-HT1A receptors”. Biochemical Pharmacology. 45 (11): 2337—41. PMID 8517875. doi:10.1016/0006-2952(93)90208-E.
Kaumann AJ (1983). „Yohimbine and rauwolscine inhibit 5-hydroxytryptamine-induced contraction of large coronary arteries of calf through blockade of 5 HT2 receptors”. Naunyn-Schmiedeberg's Archives of Pharmacology. 323 (2): 149—54. PMID 6136920. doi:10.1007/BF00634263.

nih.gov

ncbi.nlm.nih.gov

Rosengren, A. H.; Jokubka, R.; Tojjar, D.; Granhall, C.; Hansson, O.; Li, D.-Q.; Nagaraj, V.; Reinbothe, T. M.; Tuncel, J. (2009). „Overexpression of Alpha2A-Adrenergic Receptors Contributes to Type 2 Diabetes”. Science. 327 (5962): 217—20. PMID 19965390. doi:10.1126/science.1176827.
Millan MJ; Newman-Tancredi A; Audinot V; et al. (2000). „Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states”. Synapse. 35 (2): 79—95. PMID 10611634. doi:10.1002/(SICI)1098-2396(200002)35:2<79::AID-SYN1>3.0.CO;2-X.
Arthur JM, Casañas SJ, Raymond JR (1993). „Partial agonist properties of rauwolscine and yohimbine for the inhibition of adenylyl cyclase by recombinant human 5-HT1A receptors”. Biochemical Pharmacology. 45 (11): 2337—41. PMID 8517875. doi:10.1016/0006-2952(93)90208-E.
Kaumann AJ (1983). „Yohimbine and rauwolscine inhibit 5-hydroxytryptamine-induced contraction of large coronary arteries of calf through blockade of 5 HT2 receptors”. Naunyn-Schmiedeberg's Archives of Pharmacology. 323 (2): 149—54. PMID 6136920. doi:10.1007/BF00634263.
Baxter GS, Murphy OE, Blackburn TP (1994). „Further characterization of 5-hydroxytryptamine receptors (putative 5-HT2B) in rat stomach fundus longitudinal muscle”. British Journal of Pharmacology. 112 (1): 323—31. PMC 1910288 . PMID 8032658.

unc.edu

pdsp.med.unc.edu

„PDSP Ki Database”. Архивирано из оригинала 8. 11. 2013. г. Приступљено 16. 08. 2012.

web.archive.org

„PDSP Ki Database”. Архивирано из оригинала 8. 11. 2013. г. Приступљено 16. 08. 2012.